| Disease | breast cancer |
| Symptom | C0231443|musculoskeletal symptoms |
| Sentences | 1 |
| PubMedID- 20299320 | Conclusion: aromatase inhibitor therapy for postmenopausal breast cancer might be associated with common musculoskeletal symptoms and with substantial functional disability and should prompt patient education. |
Page: 1